We aimed to evaluate the impact of age on the performance of the European Society of Cardiology (ESC) 0/1h-algorithms and to derive and externally validate alternative cut-offs specific to older patients. 
Methods and results
We prospectively enrolled patients presenting to the emergency department (ED) with symptoms suggestive of acute myocardial infarction in three large diagnostic studies. Final diagnoses were adjudicated by two independent cardiologists. High-sensitivity cardiac troponin (hs-cTn) T and I concentrations were measured at presentation and after 1 h. Patients were stratified according to age [<55 years (young), > _55 to <70 years (middle-age), > _70 years (old)]. Rule-out safety of the ESC hs-cTnT 0/1h-algorithm was very high in all age-strata: sensitivity 100% [95% confidence interval (95% CI) 94.9-100] in young, 99.3% (95% CI 96.0-99.9) in middle-age, and 99.3% (95% CI 97.5-99.8) in old patients. Accuracy of rule-in decreased with age: specificity 97.0% (95% CI 95.8-97.9) in young, 96.1% (95% CI 94.5-97.2) in middle-age, and 92.7% (95% CI 90.7-94.3) in older patients. Triage efficacy decreased with increasing age (young 93%, middle-age 80%, old 55%, P < 0.001). Similar results were found for the ESC hs-cTnT 0/1h-algorithm. Alternative, slightly higher cut-off concentrations optimized for older patients maintained very high safety of rule-out, increased specificity of rule-in (P < 0.01), reduced overall efficacy for hs-cTnT (P < 0.01), while maintaining efficacy for hs-cTnI. Findings were confirmed in two validation cohorts (n = 2767).
Introduction
In patients presenting with symptoms suggestive of acute myocardial infarction (AMI), rapid identification of AMI as a life-threatening disorder, but also rapid and accurate rule-out of AMI has enormous medical and economic value. [1] [2] [3] Recently, diagnostic strategies applying high-sensitivity cardiac troponin (hs-cTn) T or I assays, including the European Society of Cardiology (ESC) 0/1h-algorithms, have been developed and facilitate the early triage towards rule-out or rule-in of AMI. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Beyond the presence or absence of AMI, age seems to be the most important confounder of hs-cTnT and hs-cTnI blood concentrations. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Mildly elevated hs-cTnT and hs-cTnI blood concentrations are common in elderly individuals without apparent ischaemic symptoms. 2, 3, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Unfortunately, the impact of age on the diagnostic performance of the ESC 0/1h-algorithms is incompletely understood.
To address this major gap in knowledge, we prospectively investigated the impact of age on the performance of the ESC 0/1h-algorithms in a large multicentre diagnostic study using central adjudication. In a second step, the age-specific findings and agedoptimized alternative cut-off concentrations for older patients derived in this multicentre study were externally validated in two additional diagnostic studies.
Methods

Study design and oversight
We enrolled adult patients presenting with suspected AMI to the emergency department (ED) in three large prospective diagnostic studies carried out according to the principles of the Declaration of Helsinki and approved by the local ethics committees: Advantageous Predictors of Acute Coronary Syndrome Evaluation (APACE, main cohort), 5, [7] [8] [9] [10] 17, [22] [23] [24] [25] [26] Biomarkers in Acute Cardiac
Care (BACC, first validation cohort), 27 and High-sensitivity cardiac Troponin T assay for RAPID rule-out of AMI (TRAPID-AMI, second validation cohort). 28 Written informed consent was obtained from all patients. The authors designed the study, gathered, and analysed the data according to the STARD guidelines 29 for studies of diagnostic accuracy (Supplementary material online, Table S1 ), vouched for the data and analysis, wrote the paper, and decided to publish. Routine clinical assessment and detailed methodological descriptions of all three cohorts are given in the Supplementary material online.
The ESC high-sensitivity cardiac troponin T and high-sensitivity cardiac troponin I 0/1h-algorithms
The concept of the ESC 0/1h-algorithms is described in detail in the Supplementary material online and shown in Supplementary material online, Figure S1 .
Stratification of patients according to age
We aimed to stratify patients by age into three equally large cohorts. Based on previous findings from APACE 5, [8] [9] [10] 22, 25, [30] [31] [32] [33] we assumed that the following three age-strata should yield near-equal group-size: <55 years (young), > _55 to <70 years (middle-age), and > _70 years (old).
Statistical analysis
Safety for rule-out was quantified by the resulting sensitivity [and negative predictive value (NPV)], accuracy for rule-in was quantified by the resulting specificity [and positive predictive value (PPV)] for non-ST-segment elevation myocardial infarction (NSTEMI) and overall efficacy was quantified by the percentage of patients triaged either towards rule-out or rule-in by the respective strategy. Time since chest pain onset (cpo) was determined at the time of first study blood draw. In the main cohort, subgroup analyses were performed in early presenters (cpo < _2 h), late presenters (cpo >6 h), and in very old patients (age > _80 years). All hypothesis testing was two-tailed, and P-values of less than 0.05 were considered to indicate statistical significance without adjustments for multiple testing. Statistical analyses were performed using SPSS for Windows, version 24.0 (SPSS Inc., Chicago, IL, USA), MedCalc, version 9.6.4.0 (MedCalc Software, Ostend, Belgium), and R (Version 3.3.1, Vienna, Austria). Detailed information is given in the Supplementary material online.
Results
Main cohort
Study cohort and characteristics of patients From April 2006 to August 2015, 3123 patients were available for the analysis of the ESC hs-cTnT 0/1h-algorithm and 2828 patients for the analysis of the ESC hs-cTnI 0/1h-algorithm (Supplementary material online, Figure S2 ). Older patients differed in multiple characteristics from younger and middle-aged patients, particularly a higher prevalence of pre-existing cardiovascular disorders including AMI and stroke ( Table 1 , Supplementary material online, Table S2 ). 
Adjudicated final diagnosis
Among patients with complete dataset of hs-cTnT, the adjudicated final diagnosis was NSTEMI in 491/3123 patients (16%), unstable angina in 301/3123 (10%), cardiac symptoms of origin other than coronary artery disease such as tachyarrhythmia, Takotsubo cardiomyopathy, heart failure or myocarditis in 476/3123 (15%), non-cardiac symptoms in 1728/3123 (55%), and unknown in 127/ 3123 patients (4%). The prevalence of NSTEMI increased with increasing age (young 6.4%, middle-aged 15%, and old 27%, P < 0.001). Distribution of final diagnoses was similar in patients with complete dataset of hs-cTnI (Supplementary material online).
High-sensitivity cardiac troponin concentrations at presentation according to age and final diagnoses and interaction between age and high-sensitivity cardiac troponin Concentrations of hs-cTnT and hs-cTnI at presentation showed a moderate-to-high correlation with age in both datasets (q = 0.6 for hs-cTnT and q = 0.49 for hs-cTnI, respectively, both P < 0.001). Old patients had significantly higher hs-cTnT and hs-cTnI concentrations at presentation than young and middle-aged patients, particularly in patients with final diagnoses other than NSTEMI (Supplementary material online, Figure S3A ,B). The interaction between age and hs-cTnT concentrations for NSTEMI was significant (P < 0.001), but not for hs-cTnI (P = 0.31) (Supplementary material online; Supplementary material online, Figure S4A ,B). Figure 2A] .
One middle-aged and two old patients with NSTEMI were missed (Supplementary material online, Table S3 ). Detailed diagnostic performance of the ESC hs-cTnT 0/1h-algorithm in decades of age is shown in Figure 2B .
Diagnostic performance of the ESC high-sensitivity cardiac troponin I 0/1h-algorithm according to age Overall, similar findings emerged when assessing the diagnostic performance of the ESC hs-cTnI 0/1h-algorithm according to age ( Figure 3 , Table 3 , Supplementary material online, Table S3 ).
Derivation of alternative cut-off criteria for the ESC highsensitivity cardiac troponin T 0/1h-algorithm Optimal alternative cut-offs for rule-out were <8 ng/L at presentation in patients presenting with a cpo >3 h or <12 ng/L at presentation and an absolute 1h-change <3 ng/L. The safety was identical to the original ESC hs-cTnT 0/1h-algorithm, but the proportion of patients eligible for direct rule-out increased from 2.2% (95% CI 1.3-3.1) to 11% (95% CI 8.9-13). The proportion of patients ruled-out overall was identical to that of the original ESC 0/1h-algorithm. For rule-in, optimal alternative cut-offs were > _80 ng/L at presentation or an absolute 1h-change > _6 ng/L. These cut-offs improved specificity from 92.7% (95% CI 90.7-94.3) to 96.8% (95% CI 95.3-97.8, P < 0.01) and PPV from 79.0% (95% CI 73.8-83.5) to 87.8% (95% CI 82.6-91.6, P = 0.04). However, the proportion of patients ruled-in for NSTEMI decreased from 25% (95% CI 23-28) to 21% (95% CI 18-24) and from 18% (95% CI 16-21) to 12% (95% CI 10-14) for direct rule-in; (Supplementary material online, Table S4A ). Accordingly, overall efficacy decreased from 55% to 51% (P < 0.001).
Derivation of alternative cut-off criteria for the ESC highsensitivity cardiac troponin I 0/1h-algorithm Optimal alternative cut-offs for rule-out were <4 ng/L at presentation in patients presenting with cpo >3 h or <6 ng/L at presentation and an absolute 1h-change <3 ng/L. The safety was similar to the original ESC hs-cTnI 0/1h-algorithm (NPV 97.5% vs. 98.1%, P = 0.67), and the proportion of patients eligible for rule-out increased from 25% (95% CI [22] [23] [24] [25] [26] [27] to 32% (95% CI 29-35) and for direct rule-out from 1.4% (95% CI 0.7-2.4) to 12% (95% CI 10-14) (Supplementary material online, Table S4B ). For rule-in, optimal alternative cut-offs were > _100 ng/L at presentation or an absolute 1h-change > _8 ng/L. These cut-offs significantly improved specificity from 86.4% (95% CI 83.7-88.7) to 90.6% (95% CI 88.3-92.5, P = 0.01), while the increase in PPV did not reach statistical significance 67.9% (95% CI 62.4-72.9) to 74.2% (95% CI 68.6-79.2, P = 0.11). Again, the proportion of patients ruled-in for NSTEMI decreased from 31% (95% CI 28-34) to 27% (95% CI [24] [25] [26] [27] [28] [29] [30] and from 23% (95% CI 20-25) to 16% (95% CI 14-19) for direct rule-in; ( Table 3 , Supplementary material online, Table  S4B ). Accordingly, overall efficacy increased from 56% to 58% (P < 0.03).
Sex-specific cut-off criteria for the ESC 0/1h-algorithms for use in older patients The diagnostic performance of derived and validated sex-specific cutoff combinations for use in older patients is shown in the Supplementary material online and Supplementary material online, Table S5A -C.
Subgroup analyses in very early presenters, late presenters, and very old patients Among 3123 patients with hs-cTnT, 830/3123 patients (27%) presented within 2 h from cpo. For example, in old patients (n = 226), 64/226 (28%) were ruled-out (sensitivity 98.5%), 62/226 (27%) ruledin (specificity 91.1%), and the remaining 100/226 (44%) patients classified as observe (Supplementary material online, Figure S5A ). Similar results were obtained for hs-cTnI (Supplementary material online, Figure S5B ). The performance of both ESC hs-cTn 0/1h-algorithms in late presenters and very old patients (age > _80 years) is given in the Supplementary material online.
Prognostic performance of the ESC high-sensitivity cardiac troponin T/I 0/1h-algorithms to predict death during follow-up Survival of young patients triaged towards rule-out, observe and rulein was 100% at 30-days for all age groups and 99.6%, 96.6%, and 95.1% at 2-years, respectively (all P < 0.001). Among middle-aged patients, survival was 99.8%, 98.4%, and 100% at 30-days, and 99.1%, 93.1%, and 96.8% at 2-years, respectively (all P < 0.001, P = 0.06 for comparison between observe and rule-in). Among old patients, survival was 99.7%, 98.7%, and 94.5% at 30-days, and 93.6%, 82.2% and 75.4% at 2-years, respectively (all P < 0.001; Supplementary material online, Figure S6A) .
Similar findings emerged when assessing the prognostic performance of the ESC hs-cTnI 0/1h-algorithm (Supplementary material online, Figure S6B ) and for the prediction of major adverse cardiac events within 30 days (Supplementary material online) .
Validation cohorts
Overall, the characteristics of patients in validation cohort 1 and validation cohort 2 were similar to those of the main cohort (Supplementary material online, Tables S6 and S7) . Diagnostic accuracy of high-sensitivity cardiac troponin T Areas under the curves of hs-cTnT and hs-cTnI concentrations at presentation in young, middle-aged, and old patients in both validation cohorts were similar to AUCs in the main cohort ( Figure 1B,C) .
Diagnostic performance of the official ESC highsensitivity cardiac troponin 0/1h-algorithms and validation of the alternative cut-off criteria in old patients In both validation cohorts, findings for the ESC hs-cTnT 0/1h-algorithm (and for the hs-cTnI 0/1h-algorithm in the first validation cohort) were similar to the findings of the main cohort. While safety remained high in older patients, specificity among patients triaged towards rule-in and particularly overall efficacy decreased with increasing age (Figure 4 , Tables 4-6, Supplementary material online, Figures  7-9 ).
Prognostic performance of the ESC high-sensitivity cardiac troponin 0/1h-algorithms to predict death during follow-up Prognostic performance of the ESC 0/1h-algorithms in both validation cohorts was similar to the prognostic performance in the main cohort (Supplementary material online; Supplementary material online, Figure S10 ).
Discussion
This large multicentre study quantified the impact of age on the performance of the ESC 0/1h-algorithms. In a second step, we derived and externally validated alternative cut-off criteria optimized for the use in older patients. We report eight major findings:
First, increasing age was associated with a higher prevalence of pre-existing cardiovascular disorders. Second, while patients adjudicated to have NSTEMI had comparable hs-cTnT and hs-cTnI concentrations among the three age-strata, hs-cTnT, and hs-cTnI concentrations were significantly higher in older patients with other causes of acute chest discomfort. This finding seems at least in part explained by the higher prevalence of pre-existing cardiovascular disorders and their association with chronic myocardial injury in older patients. Third, accordingly the overlap in hs-cTnT and hs-cTnI concentrations between NSTEMI and other causes of acute chest discomfort was larger resulting in a lower AUC with increasing age. The interaction term (hs-cTn*age) for NSTEMI was statistically significant when using hs-cTnT, but not when using hs-cTnI, possibly suggesting different effects of aging on hs-cTnT vs. hs-cTnI concentrations. Fourth, the prevalence of NSTEMI increased substantially with increasing age and was more than four times higher in older vs. younger patients. Fifth, age had a major impact on the overall diagnostic performance of the ESC 0/1h-algorithm: while safety as quantified Figure 2 Diagnostic performance of the ESC high-sensitivity cardiac troponin T 0/1h-algorithm according to age in the main cohort. Diagnostic performance of the ESC high-sensitivity cardiac troponin T 0/1h-algorithm in patients stratified according to age into (A) young, middle-age, old, and (B) decades. a If chest pain onset >3 h; D, unsigned change within the first hour; hs-cTnT, high-sensitivity cardiac troponin T; NPV, negative predictive value; NSTEMI, non-ST-segment elevation myocardial infarction; PPV, positive predictive value; Prev., prevalence; Sens., sensitivity; Spec., specificity. by sensitivity and NPV was very high in all age-strata, the percentage of patients assigned towards rule-out, the specificity among patients triaged towards rule-in, and particularly overall efficacy decreased with increasing age. As a consequence, the percentage of old patients remaining in the observe zone and usually requiring additional diagnostic testing including a 3h-sample of hs-cTn and cardiac imaging was nearly twice as high as in middle-aged and more than four times as high as in young patients. Due to the increase in AMI prevalence with age, PPV remained high in older patients. Sixth, use of individualized slightly higher cut-offs in older patients maintained very high safety of rule-out, increased specificity of rule-in, reduced overall efficacy for hs-cTnT, while maintaining efficacy for hs-cTnI. Accordingly, the use of slightly higher cut-off concentrations may be considered, particularly if using hs-cTnI. Still, the overall improvement achieved was modest and needs to be balanced against the increased complexity created by specific cut-offs in elderly patients. Using sex-specific cut-off criteria vs. modified cut-off criteria in older patients did not further increase the overall diagnostic performance of both ESC 0/ 1h-algorithms. Beyond age, also the time from cpo, sex, and renal function have been shown to affect hs-cTnT and hs-cTnI concentrations. Although preliminary evidence suggests that the effect of these additional confounders overall is smaller as compared to that of age, 1,2,12,15,34 computerized integration of all confounders might be the most accurate approach once convenient physician-information technology interfaces become available. Seventh, while the vast majority of findings for the ESC 0/1h-algorithm using hs-cTnI mirrored the findings for the ESC 0/1h-algorithm using hs-cTnT, safety of ruleout and accuracy of rule-in were slightly lower for hs-cTnI as (15) 26 (14) 65 (14) 0.83 0.95 87 (17) <0.001
Numbers are presented as numbers (%) and percentage with 95% confidence interval. NPV, negative predictive value; NSTEMI, non-ST-segment elevation myocardial infarction; PPV, positive predictive value. a P-value for differences between young and middle-aged patients.
b P-value for differences between middle-aged and old patients. compared to hs-cTnT. At first glance, this finding is surprising as both assays seem to have comparable diagnostic accuracy for NSTEMI, 23 and hs-cTnI-Architect seems to have even higher analytical sensitivity as compared to hs-cTnT-Elecsys. 35 This finding is therefore more likely related to the inherent verification bias in favour of hs-cTnT (available among many other information for the adjudication) as compared to hs-cTnI (not available for the adjudication) and the rare, but previously described analytical discrepancies between hs-cTnI and hs-cTnT. 8, 31 Eighth, irrespective of age, patients triaged towards rule-out had very high 30-day survival rates of 99-100%. As expected, 30-day and 1-year or 2-year survival rates were lower in older patients as compared to younger patients.
Our findings extend and corroborate data previously obtained for the diagnostic performance of the ESC 0/1h-algorithm assessed in allcomers with acute chest discomfort. 7, 8, 10, 22, 33 These findings also extend and corroborate more general observations made for the use of hs-cTn in elderly patients. 36 The clinical utility of the ESC 0/1h-algorithms also remained high in very old patients (> _80 years) and those presenting very early after cpo. While patients presenting early to the ED were more frequently ruled-in by significant 1h-delta changes, late presenters were primarily ruled-in due to markedly elevated cardiac troponin (cTn) concentrations. This can be explained by the fact that the increase in cTn concentrations is time-dependent. Due to ............................................................................................................................................................................................................ ..... Numbers are presented as n (%) and percentage with 95% confidence interval. NPV, negative predictive value; NSTEMI, non-ST-segment elevation myocardial infarction; PPV, positive predictive value. a P-value for differences between young and middle-aged patients.
b P-value for differences between middle-aged and old patients. Numbers are presented as numbers (%) and percentage with 95% confidence interval. NPV, negative predictive value; NSTEMI, non-ST-segment elevation myocardial infarction; PPV, positive predictive value. a P-value for differences between young and middle-aged patients.
b P-value for differences between middle-aged and old patients. the higher prevalence of NSTEMI, PPV in older patients was even higher (70-80%) as in younger patients, and in a range that most experts consider an acceptable likelihood to initiate invasive management in the majority of these patients. The additional use of short-term changes as criteria within the ESC 0/1h-algorithms at least in part was able to compensate for the substantially lower specificity of mild elevations in hs-cTn in older patients. 36 The lower efficacy observed in older patients is not unique to the ESC 0/1h-algorithms, but seems to be a universal phenomenon of all Numbers are presented as numbers (%) and percentage with 95% confidence interval. NPV, negative predictive value; NSTEMI, non-ST-segment elevation myocardial infarction; PPV, positive predictive value. a P-value for differences between young and middle-aged patients.
b P-value for differences between middle-aged and old patients. Impact of age on the ESC 0/1h-algorithms currently available diagnostic algorithms. 2, 3, 37 The higher prevalence of cardiovascular comorbidities in older patients invariably reduces the diagnostic performance of clinical assessment, the electrocardiography (ECG), hs-cTn, and cardiac imaging. 2, 3, 37 The exact pathophysiological mechanisms resulting in cardiomyocyte injury in the aging heart are incompletely understood, but seem to include the effect of pre-existing cardiovascular disorders such as previous AMI, hypertensive heart disease, as well as myocardial fibrosis. 2, 3, 38 It is important to highlight that irrespective of the use of the uniform or individualized cut-offs in older patients, the ESC 0/1h-algorithms should always be used in conjunction with full clinical assessment and the ECG. Accordingly, the final sensitivity achieved by the combination of both ESC 0/1h-algorithms with clinical assessment and the ECG will be even slightly higher as that reported for the ESC 0/1h-algorithms only. Vice versa, efficacy will be slightly lower as the clinician will overrule the triage recommendation provided by the algorithm in some patients.
Some limitations merit consideration when interpreting these findings. First, our study was conducted in ED patients with symptoms suggestive of AMI. Further studies are required to quantify the utility of the ESC 0/1h-algorithms in patients with either a higher pre-test probability (e.g. in a coronary care unit setting) or in patients with a lower pre-test probability (e.g. in a general practitioner setting) for AMI. Second, no specific sample size calculation was performed. Although this secondary analysis from an ongoing multicentre study is one of the largest ever performed, it still may have been underpowered for some comparisons. Third, not all patients with acute chest pain had a second set of laboratory measurements at 1 h. The most common reasons for missing blood samples were logistic issues in the ED that precluded blood draw around the 1h-window. However, it is unlikely that the absence of these patients significantly influenced our results. Fourth, although we used the most stringent methodology to adjudicate the presence or absence of AMI including central adjudication by experienced cardiologists and serial measurements of hs-cTn, we still may have misclassified a small number of patients. 39 Fifth, our findings are specific to the two hs-cTn assays currently available for routine clinical care. Once other hs-cTn assays will become available for clinical care, additional studies will need to derive and validate a 0/1h-algorithm and examine whether our findings can be generalized to them. Finally, we cannot generalize our findings to patients with terminal kidney failure requiring dialysis, since they were excluded from this study.
Conclusion
While the safety of the ESC 0/1h-algorithms remained very high, increasing age significantly reduced overall efficacy, and the accuracy of rule-in. Alternative slightly higher cut-off concentrations may be considered for older patients, particularly if using hs-cTnI.
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